Advertisement
Sino Agro Food, Inc.

SIAF News Today: Stay Updated with the Latest Sino Agro Food, Inc. News in Real Time

Find SIAF news now at Meyka AI. Stay informed with the latest Sino Agro Food, Inc. stocks updates, including price news, market analysis, and expert insights.

SIAFPNK
Consumer DefensiveAgricultural Farm Products
$0.00
$0.00(0.00%)
U.S. Market is Open · 09:43
Advertisement
China’s Factory-Gate Inflation Hits 3.9% in May, Highest Since 2022
📅 in about 4 hours

China’s Factory-Gate Inflation Hits 3.9% in May, Highest Since 2022

China’s producer prices rose 3.9% in May to a 4-year high amid Iran tensions and AI demand, while consumer inflation lagged at 1.2%.

Read more 12
NVIDIA Corp (NVDA -0.22% / -1.78% Pre-Market) Leads AI Chip Stocks Drop as AMD (-3.02%), Intel (-2.13%), and Micron (-1.41%) Decline 
📅 in about 3 hours

NVIDIA Corp (NVDA -0.22% / -1.78% Pre-Market) Leads AI Chip Stocks Drop as AMD (-3.02%), Intel (-2.13%), and Micron (-1.41%) Decline 

NVIDIA shares fell 1.78% in pre-market trading on June 10, 2026, leading a broader decline across AI chip stocks. AMD dropped 3.02%, while Intel and Micron also traded lower as investors reacted to renewed concerns over inflation, interest rates, and technology valuations.  The selloff comes after a powerful AI-driven rally that pushed semiconductor stocks to…

Read more 12
SK Hynix Eyes U.S. Listing as Early as August Amid Strong AI Stock Demand 
📅 in about 2 hours

SK Hynix Eyes U.S. Listing as Early as August Amid Strong AI Stock Demand 

SK Hynix is moving closer to a major milestone in its global growth strategy. Reports on June 10, 2026, revealed that the South Korean memory-chip giant is considering a U.S. stock market listing as early as August.  The timing comes as artificial intelligence continues to fuel strong demand for advanced semiconductor companies. With investors pouring…

Read more 12
Concord Biotech Shares Jump 5.9% After US FDA Approves Tofacitinib Arthritis Drug
📅 in 22 minutes

Concord Biotech Shares Jump 5.9% After US FDA Approves Tofacitinib Arthritis Drug

Shares of Concord Biotech saw strong buying interest after a key global development. The stock rose around 5.9% in recent trading sessions after news of a US FDA approval related to its Tofacitinib-based arthritis drug. The trigger is important. The US Food and Drug Administration (FDA) approval opens doors to the world’s largest pharmaceutical market….

Read more 12
Xi’s North Korea Visit Signals Shift on Nuclear Weapons, June 10
📅 12 minutes ago

Xi’s North Korea Visit Signals Shift on Nuclear Weapons, June 10

Xi Jinping visits North Korea for first time in seven years, avoiding nuclear talks and signaling China’s acceptance of Pyongyang’s weapons arsenal.

Read more 12
Chrisleys Sue Former Attorney for $25M Over Legal Malpractice, June 09
📅 6 hours ago

Chrisleys Sue Former Attorney for $25M Over Legal Malpractice, June 09

Todd and Julie Chrisley sue attorney Chris Anulewicz and Balch & Bingham for $25M, alleging legal malpractice led to convictions and prison time.

Read more 12
Iran War Costs UK Economy £25 Billion in Added Expenses, June 10
📅 8 hours ago

Iran War Costs UK Economy £25 Billion in Added Expenses, June 10

Iran war adds £25 billion in costs for UK and global firms as energy prices surge and supply chains face disruption.

Read more 12
South Korea Blocks Japan Military Pact Over Colonial Apology, June 10
📅 16 hours ago

South Korea Blocks Japan Military Pact Over Colonial Apology, June 10

South Korea blocks ACSA military agreement with Japan, citing unresolved colonial history and public opposition to defense cooperation.

Read more 12
United Natural Foods Stock Plunges 11% After $7.72B Revenue Miss and Weak FY2026 Outlook
📅 20 hours ago

United Natural Foods Stock Plunges 11% After $7.72B Revenue Miss and Weak FY2026 Outlook

Revenue came in. The stock came down. United Natural Foods (NYSE: UNFI) reported fiscal Q3 2026 results before the market open on June 9, 2026, covering the 13 weeks ended May 2, 2026. Wall Street had set the bar at $7.80 billion in revenue and $0.77 EPS, based on consensus estimates from 10 analysts. The…

Read more 12

SIAF News FAQ